Survival similar for Black, White prostate cancer patients in clinical trial setting
For metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors ...
Aug 4, 2023
0
35